glecaprevir
Showing 1 - 25 of 69
Ptsd Trial in White River Junction (Glecaprevir / Pibrentasvir Pill)
Not yet recruiting
- Ptsd
- Glecaprevir / Pibrentasvir Pill
-
White River Junction, VermontWhite River Junction VAMC
Dec 12, 2022
Ptsd Trial in White River Junction (Glecaprevir/pibrentasvir, Placebo)
Not yet recruiting
- Ptsd
- Glecaprevir/pibrentasvir
- Placebo
-
White River Junction, VermontWhite River Junction VAMC
Dec 12, 2022
ESRD Trial in New York (Glecaprevir/pibrentasvir)
Enrolling by invitation
- ESRD
-
New York, New YorkNYU Langone Health
Aug 5, 2022
Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin
Recruiting
- Hepatitis C Infection
- HIV Infection
- Glecaprevir/Pibrentasvir (G/P)
- Ribavirin (RBV)
-
San Diego, California
- +15 more
Dec 19, 2022
Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))
Recruiting
- Hepatitis C
- Sofosbuvir 400mg [Sovaldi]
- Glecaprevir/pibrentasvir (300mg/120mg)
-
Darlinghurst, New South Wales, Australia
- +2 more
Mar 28, 2022
End Stage Renal Disease, Hepatitis C Trial in Baltimore (Glecaprevir/pibrentasvir)
Active, not recruiting
- End Stage Renal Disease
- Hepatitis C
-
Baltimore, MarylandJohns Hopkins Hospital
Dec 7, 2021
Hepatitis C Trial in Long Island City, New York (diagnostic test, other, drug)
Recruiting
- Hepatitis C
- Cepheid POC HCV Viremia (RNA) test
- +2 more
-
Long Island City, New York
- +2 more
Dec 20, 2022
Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac
Active, not recruiting
- Cardiovascular Diseases
- +2 more
- Elbasvir / Grazoprevir Oral Tablet [Zepatier]
- Cardiac MRI
-
Washington, District of Columbia
- +1 more
Feb 1, 2023
Oral Glecaprevir/Pibrentasvir Tablet In Pediatric And Adult
Completed
- Hepatitis C Virus (HCV)
-
Chelyabinsk, Russian Federation
- +5 more
Jun 8, 2022
End Stage Renal Disease, Hepatitis C Trial in Baltimore (300mg glecaprevir/pibrentasivir 120mg)
Completed
- End Stage Renal Disease
- Hepatitis C
- 300mg glecaprevir/pibrentasivir 120mg
-
Baltimore, MarylandJohns Hopkins University
Sep 21, 2021
Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6
Completed
- Hepatitis C Virus (HCV)
-
Makhachkala, Dagestan, Respublika, Russian Federation
- +7 more
Jun 23, 2022
Hepatitis C, Liver Inflammation, Liver Cirrhoses Trial in Australia (Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet,
Recruiting
- Hepatitis C
- +2 more
- Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
- Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
-
Randwick, New South Wales, Australia
- +6 more
Mar 28, 2022
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric
Completed
- Hepatitis C Virus (HCV)
- Glecaprevir/pibrentasvir adult formulation
- Glecaprevir/pibrentasvir pediatric formulation
-
San Francisco, California
- +37 more
Sep 19, 2022
Kidney Failure, Hepatitis C, Kidney Disease, Chronic Trial in Boston (Glecaprevir and Pibrentasvir)
Recruiting
- Kidney Failure
- +2 more
- Glecaprevir and Pibrentasvir
-
Boston, MassachusettsMassachusetts General Hospital
Jun 4, 2021
Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of Trial in San Diego (glecaprevir/pibrentasvir (GLE/PIB))
Completed
- Hepatitis C
- Hepatitis C Virus Infection, Response to Therapy of
- glecaprevir/pibrentasvir (GLE/PIB)
-
San Diego, CaliforniaUniversity of California San Diego
May 23, 2022
Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)
Recruiting
- Hepatitis C
- HCV RNA Point of Care
- +2 more
-
Sydney, New South Wales, AustraliaNUAA NSP
Aug 19, 2022
Renal Failure Chronic, Hepatitis C Trial in United States (glecaprevir/pibrentasvir treatment)
Completed
- Renal Failure Chronic
- Hepatitis C
- glecaprevir/pibrentasvir treatment
-
Chicago, Illinois
- +6 more
Jan 18, 2022
Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12
Active, not recruiting
- Hepatitis C Virus (HCV)
-
Chelyabinsk, Russian Federation
- +9 more
Mar 1, 2022
Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Hepatitis C, Kidney Transplant; Complications, Heart Transplant Infection Trial in Scottsdale (Mavyret)
Active, not recruiting
- Hepatitis C
- +2 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Mar 4, 2022
End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])
Withdrawn
- End Stage Renal Disease
- Chronic Hepatitis c
- Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
-
Boston, MassachusettsMassachusetts General Hospital
Mar 4, 2022
Clinical Practice Use of Glecaprevir Plus Pibrentasvir in
Completed
- Chronic Hepatitis C (CHC)
-
Samara, Samarskaya Oblast, Russian Federation
- +8 more
Aug 25, 2021
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- ABT-493/ABT-530
- +2 more
- (no location specified)
Jul 14, 2021
Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)
Completed
- Chronic Hepatitis C Virus
- Hepatitis C Virus
- (no location specified)
Jul 14, 2021